Deltyba 25 mg dispersible tablets

Licence status
Authorised: 16/09/2021
Active substances
Delamanid
Dosage Form
Dispersible tablet
Licence number
EU/1/13/875/005
Licence holder
Otsuka Novel Products GmbH

Product documents

Licence information

ATC code
J04AK06 delamanid
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal products subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/09/2021